ストックスクリーナーアプリを入手
44.06
2.59%
-1.17
プレマーケット:
44.37
0.31
+0.70%
前日終値:
$45.23
開ける：
$45.04
24時間の取引高:
931.46K
Relative Volume:
1.12
時価総額：
$1.92B
収益：
$1.24B
当期純損益:
$23.68M
株価収益率:
104.90
EPS:
0.42
ネットキャッシュフロー:
$108.67M
1週間 パフォーマンス:
+25.31%
1か月 パフォーマンス:
+29.74%
6か月 パフォーマンス:
-17.77%
1年 パフォーマンス:
-27.94%
1日の値動き範囲:
$44.03
$45.19
1週間の範囲:
$39.36
$45.77
52週間の値動き範囲:
$32.48
$63.57
Livanova Plc Stock (LIVN) Company Profile
LIVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
44.06 | 1.92B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
LIVN Stock Rating Reiterated at 'Buy' by Needham Analyst | LIVN - GuruFocus
LivaNova PLC (NASDAQ:LIVN) Q1 2025 Earnings Call Transcript - Insider Monkey
How to Take Advantage of moves in (LIVN) - news.stocktradersdaily.com
LivaNova PLC: Strong Growth Amidst Challenges in Earnings Call - TipRanks
Electroceuticals Market Top PlayersMedtronic Plc (Ireland), - openPR.com
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator - Sleep Review
Jefferies lifts Livanova stock price target to $79 from $74 - Investing.com Australia
LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus
LivaNova Q1 2025 revenue increases 7.4% to USD 316.9M - Medical Buyer
Barclays Adjusts LivaNova (LIVN) Price Target Amid Strong Performance | LIVN Stock News - GuruFocus
LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo Finance
LivaNova PLC Reports Strong Q1 2025 Results - TipRanks
Jefferies lifts Livanova stock price target to $79 from $74 By Investing.com - Investing.com South Africa
LivaNova: Q1 Earnings Snapshot - MySA
LivaNova PLC earnings beat by $0.12, revenue topped estimates - Investing.com Nigeria
LivaNova PLC SEC 10-Q Report - TradingView
Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
LivaNova Q1 2025 Earnings Call Transcript - MarketBeat
Will LivaNova's Growth And Innovation Drive Sustained Gains In 2025? - Nasdaq
LivaNova submits nerve stim for sleep apnea to FDA, raises 2025 guidance - MassDevice
LivaNova Q1 Adjusted Earnings, Net Revenue Rise; 2025 Outlook Revised - marketscreener.com
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
LIVN Surpasses Q1 Revenue Expectations with Robust Growth | LIVN Stock News - GuruFocus
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - BioSpace
LivaNova PLC Q1 2025 Earnings: Revenue Hits $316.9M, Adjusted EPS Soars to $0.88, Both Surpass Estimates - GuruFocus
LIVN Reports Promising 12-Month Results from OSPREY Sleep Apnea Trial | LIVN Stock News - GuruFocus
LivaNova plc (LIVN) Tops Q1 EPS by 12c ; Offers Guidance - StreetInsider
Earnings Flash (LIVN) LIVANOVA PLC Reports Q1 Revenue $316.9M, vs. FactSet Est of $302.4M - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy | LIVN Stock News - GuruFocus
LivaNova Announces 12-Month Data From Osprey Clinical Study For Moderate To Severe Obstructive Sleep Apnea, Demonstrating Strong Response And Durability Of Therapy - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy - Business Wire
Should Weakness in LivaNova PLC's (NASDAQ:LIVN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st
How the (LIVN) price action is used to our Advantage - news.stocktradersdaily.com
Medical Implants Market Projected To Witness Substantial - openPR.com
Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? - Insider Monkey
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
Mizuho Adjusts Price Target for LivaNova (LIVN) Ahead of Q1 Prev - GuruFocus
What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing? - Yahoo Finance
LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires - Insider Monkey
Cardiovascular Devices Market Demand, Growth and Future Scope - openPR.com
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
With LivaNova PLC (NASDAQ:LIVN) It Looks Like You'll Get What You Pay For - simplywall.st
Aortic Stenosis Market to Witness Massive Growth by 2032 | - openPR.com
10 Best UK Stocks to Buy According to Billionaires - Insider Monkey
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
0.94%
大文字化:
|
ボリューム (24 時間):